PC

Prakash Chandra Pradhan

Active Director Director DIN 11880017
DIN 11880017 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Prakash Chandra Pradhan

Prakash Chandra Pradhan is a Director at N P Ashwini Medicis (Opc) Private Limited (since 2026).

DIN 11880017
Primary Designation Director
First Appointment 10 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Aug 20262026Active

Board colleagues of Prakash Chandra Pradhan

NameDINCompanyDesignation
Monalisa PradhanN P Ashwini Medicis (Opc) Private LimitedNominee

Directorship timeline

Open interactive timeline →
N P Ashwini Medicis (Opc) Private Limited
Premium access

Shareholding and investment profile for Prakash Chandra Pradhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Chandra Pradhan

Prakash Chandra Pradhan currently holds 1 directorship: N P Ashwini Medicis (Opc) Private Limited (Director, since 10 Aug 2026).

Prakash Chandra Pradhan was first appointed on 10 Aug 2026 as Director at N P Ashwini Medicis (Opc) Private Limited.

The current boards of Prakash Chandra Pradhan's companies include Monalisa Pradhan (N P Ashwini Medicis (Opc) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available